FDA-001Critical
Branded-drug equivalence claim
/semaglutide
Same active ingredient as Ozempic®FDA-001, without the brand-name price.
Reference: FD&C Act misbranding provisions; FDA statements on compounded GLP-1 products
RemediationRemove the equivalence claim. State that compounded semaglutide is not FDA-approved and is not the same as branded products.